Back to results

print
Platelia Apsergillus Antigen EIA test for Invasive Aspergillosis in high risk patients

Source agency:
NHSC
Date of Submission:
25/03/2010
Date of Printing:
05/02/2012
Technology name:
Platelia Apsergillus Antigen enzyme immunoassay (EIA) test
Technology - type(s):
Diagnostics
Patient indications:
Neutropenic patients, especially those at high risk for Invasive Aspergillosis (IA), e.g. transplant patients and those receiving chemotherapy for haematological malignancies or lymphoma.